These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9045344

  • 21. Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.
    Choy H, Safran H, Akerley W, Graziano SL, Bogart JA, Cole BF.
    Clin Cancer Res; 1998 Aug; 4(8):1931-6. PubMed ID: 9717821
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response.
    Glantz MJ, Choy H, Akerley W, Kearns CM, Egorin MJ, Rhodes CH, Cole BF.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):128-35. PubMed ID: 9007140
    [Abstract] [Full Text] [Related]

  • 24. Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: preliminary results of phase II trial.
    Hainsworth JD, Meluch AA, Greco FA.
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-38-S19-42. PubMed ID: 9427264
    [Abstract] [Full Text] [Related]

  • 25. A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer.
    Lee JS, Komaki R, Morice RC, Ro JY, Kalapurakal SK, Schea R, Murphy WK, Shin DM, Fox NT, Walsh GL, Hittelman WN, Hong WK.
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):121-9. PubMed ID: 10210551
    [Abstract] [Full Text] [Related]

  • 26. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.
    Socinski MA, Clark JA, Halle J, Steagall A, Kaluzny B, Rosenman JG.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135
    [Abstract] [Full Text] [Related]

  • 27. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
    Nguyen NP, Leonardo JM, Karlsson U, Vos P, Bullock L, Thomas P, Lepera P, Ludin A, Chu C, Salehpour M, Jendrasiak G, Sallah S.
    Anticancer Res; 2002 Oct; 22(6B):3429-35. PubMed ID: 12552935
    [Abstract] [Full Text] [Related]

  • 29. Paclitaxel in head and neck and other cancers: future prospects.
    Aisner J, Cortés-Funes H.
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-113-S2-115. PubMed ID: 9045328
    [Abstract] [Full Text] [Related]

  • 30. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
    Leonard CE, Chan DC, Chou TC, Kumar R, Bunn PA.
    Cancer Res; 1996 Nov 15; 56(22):5198-204. PubMed ID: 8912857
    [Abstract] [Full Text] [Related]

  • 31. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ, Meyers FJ, Houston J, Lauder I.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [Abstract] [Full Text] [Related]

  • 32. Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity.
    Robert F, Childs HA, Spencer SA, Redden DT, Hawkins MM.
    Semin Radiat Oncol; 1999 Apr 15; 9(2 Suppl 1):136-47. PubMed ID: 10210553
    [Abstract] [Full Text] [Related]

  • 33. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ, Millenson M, Rosvold E, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [Abstract] [Full Text] [Related]

  • 34. Paclitaxel and concurrent radiotherapy in locally advanced non-small cell lung cancer: the Canadian experience.
    Kirkbride P, Gelmon K, Eisenhauer E.
    Semin Radiat Oncol; 1999 Apr 15; 9(2 Suppl 1):102-7. PubMed ID: 10210548
    [Abstract] [Full Text] [Related]

  • 35. High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.
    Socinski MA, Shea TC.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-45-S12-51. PubMed ID: 9331121
    [Abstract] [Full Text] [Related]

  • 36. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
    Adamo V, Ferraro G, Pergolizzi S, Sergi C, Laudani A, Settineri N, Alafaci E, Scimone A, Spano F, Spitaleri G.
    Oral Oncol; 2004 May 15; 40(5):525-31. PubMed ID: 15006626
    [Abstract] [Full Text] [Related]

  • 37. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP.
    Semin Oncol; 1999 Feb 15; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [Abstract] [Full Text] [Related]

  • 38. Thoracic radiation therapy and concomitant low-dose daily paclitaxel in non-small cell lung cancer: a phase I study.
    Gobitti C, Franchin G, Minatel E, Gigante M, Basso B, Bujor L, Trovò MG.
    Oncol Rep; 2005 Dec 15; 14(6):1647-53. PubMed ID: 16273271
    [Abstract] [Full Text] [Related]

  • 39. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
    Chang AY, Boros L, Asbury R, Hui L, Rubins J.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098
    [Abstract] [Full Text] [Related]

  • 40. Role of p53 and p16 gene alterations in determining response to concurrent paclitaxel and radiation in solid tumor.
    King TC, Estalilla OC, Safran H.
    Semin Radiat Oncol; 1999 Apr 15; 9(2 Suppl 1):4-11. PubMed ID: 10210535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.